The Role of Gene Therapy in Premature Ovarian Insufficiency Management

The Role of Gene Therapy in Premature Ovarian Insufficiency Management

Premature ovarian insufficiency (POI) is a highly prevalent disorder, characterized by the development of menopause before the age of 40. Most cases are idiopathic; however, in some women the cause of this condition (e.g.; anticancer treatment, genetic disorders, and enzymatic defects) could be iden...

Full description

Bibliographic Details
Main Authors: Ihor Atabiekov, Elie Hobeika, Ujalla Sheikh, Abdeljabar El Andaloussi, Ayman Al-Hendy
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Biomedicines
Subjects:
premature ovarian insufficiency
POI
gene therapy
menopause
<i>SAL-like 4</i> genes
SALL4
follicle-stimulating hormone (FSH)
basonuclin-1
replication-incompetent adenoviral vector
Ad
stem cells
SC
Online Access:https://www.mdpi.com/2227-9059/6/4/102

Internet

https://www.mdpi.com/2227-9059/6/4/102

Similar Items